ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ONMD vs MXCT // EV/EBITDA & P/E VALUATION

OneMedNet Corp (Class A) (NASDAQ) VS. MaxCyte Inc. (NASDAQ) • 15-METRIC TALLY: ONMD 1 — MXCT 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ONMD VS. MXCT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ONMD MXCT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% 96.00% -126.00 MXCT /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -27.10% -7.90 MXCT /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — -20.26% — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 111.40% -5.70% +117.10 ONMD /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 1.52 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 MXCT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 37.7 65.4 -27.62 MXCT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $26.3M $178.5M -$152.3M MXCT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ONMD REV MXCT REV ONMD GROSS % MXCT GROSS % ONMD FCF MXCT FCF
FY 2025 $1.4M $21.0M -37.0% 98.0% -$7.5M -$36.2M
FY 2024 $643.0K $22.2M -43.7% 98.0% -$7.0M -$29.3M
FY 2023 $1.0M $19.5M — — -$4.8M -$21.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ONMD // BETA —
MXCT // BETA —